All stock acquisition rights (4th series) were fully exercised, resulting in issuance of 1,012,600 shares and an increase in the total number of outstanding shares. Total exercise proceeds amounted to approximately 1,999,885,000 yen, and there are no unexercised rights remaining. The funds will be used as M&A standby funds.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4078","jir_company_name":"Sakai Chemical Industry Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-26","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4078-20261026-01.pdf","jir_short_summary":"All stock acquisition rights (4th series) were fully exercised, resulting in issuance of 1,012,600 shares and an increase in the total number of outstanding shares. Total exercise proceeds amounted to approximately 1,999,885,000 yen, and there are no unexercised rights remaining. The funds will be used as M&A standby funds.","jir_summary":"### Completion of Exercise of Stock Acquisition Rights and Issuance of New Shares\nSakai Chemical Industry Co., Ltd. announced that all of the 4th series stock acquisition rights issued in June 2023 have been fully exercised, and new shares are planned to be issued by October 26, 2026. The number of shares to be delivered is 1,012,600 shares; all 10,126 stock acquisition rights were exercised, representing an exercise ratio of 100.0% against the total issued rights. There are 0 unexercised shares remaining, and funds of 1,999,885,000 yen were raised.\n\n### Capital Policy and Use of Funds\nAll proceeds from the exercise of these stock acquisition rights will be allocated as M&A standby funds to support expansion of growth businesses. Specific M&A targets have not been decided at this time; if funds cannot be allocated within the designated period, they will be considered for use in R&D investment, new business investment, and similar purposes. This is not expected to affect the annual dividend forecast of 160 yen published in August 2026.","jir_financial_highlights":"Shares issued at start of month: 1,012,600 shares (Unknown)\nNumber of stock acquisition rights exercised: 10,126 units (Unknown)\nExercise ratio to total issued stock acquisition rights: 100.0% (Unknown)\nTotal face value of exercised stock acquisition rights: 1,999,885,000 yen (Unknown)\nUnexercised remaining amount as of now: 0 yen (Unknown)","jir_category":"","jir_hashtags":"#SakaiChemicalIndustry, #ExerciseOfStockAcquisitionRights, #CapitalPolicyTrends","jir_key_figures":"Number of shares issued upon grant of stock acquisition rights: 1,012,600 shares\nNumber of stock acquisition rights exercised: 10,126 units\nTotal face value of exercised rights: 1,999,885,000 yen","jir_meta_title":"Sakai Chemical Industry Co., Ltd. - Completion of Exercise of 4th Stock Acquisition Rights\uff5cIssuance of New Shares and M&A Standby Funds","jir_meta_description":"Sakai Chemical Industry Co., Ltd. has completed full exercise of the 4th stock acquisition rights and will issue 1,012,600 new shares. Total exercise proceeds amount to approximately 1,999,885,000 yen, intended to be used as M&A standby funds. No impact on dividend forecast is expected.","jir_og_title":"Sakai Chemical Industry Co., Ltd. Announces Completion of Exercise of Stock Acquisition Rights and Issuance of New Shares","jir_og_description":"Sakai Chemical Industry Co., Ltd. has fully exercised the 4th stock acquisition rights and will issue 1,012,600 shares. Proceeds are planned for use as M&A standby funds, with no expected impact on the dividend forecast.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17304,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-134298","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n